Home / Current Issue / Paper 1711923
Developing a Strategic Procurement Optimization Model for Cost Efficiency in Pharmaceutical Manufacturing
Subject area: Management and Commerce · Area of research: Strategic Procurement Optimization Model
Abstract
Pharmaceutical manufacturers face converging pressures from price controls, raw-material volatility, supply disruptions, and strict regulatory oversight, making procurement a decisive lever for durable cost efficiency. This paper proposes a Strategic Procurement Optimization Model (SPOM) tailored to pharmaceutical manufacturing that unifies demand forecasting, multi-criteria supplier evaluation, risk-adjusted total cost of ownership, and scenario-driven inventory policies. The model couples probabilistic demand signals with mixed-integer programming to allocate volumes across qualified suppliers while honoring current Good Manufacturing Practice (cGMP), audit status, and validated change-control requirements. It explicitly prices risk via Monte Carlo stress tests on lead times, yields, and currency exposures, producing service-level-constrained decisions that minimize expected landed cost. The SPOM architecture consists of three layers. The data and analytics layer consolidates internal consumption histories, quality deviations, supplier scorecards, and external market indices to build transparent should-cost models for active pharmaceutical ingredients, excipients, and packaging. The optimization layer encodes constraints for batch sizes, shelf-life, cold-chain requirements, audit status, and dual-sourcing rules; it evaluates price-volume breakpoints, near-shoring options, consignment or vendor-managed inventory, and capacity reservations. The governance layer embeds cross-functional tollgates and key risk indicators, aligning sourcing decisions with Quality, Regulatory Affairs, Supply Chain, and Finance. Implementation is staged: taxonomy harmonization; digital RFx with structured technical and quality questionnaires; baseline risk and cost diagnostics; optimization runs with what-if scenarios (supplier outage, lead-time shocks, currency swings, expedited freight caps); and execution through category roadmaps with measurable targets. A pilot design for a solid-dose portfolio indicates potential outcomes: 6?12% reduction in addressable spend via mix and price leverage; 15?25% decrease in working capital through right-sized safety stocks; and improved resilience evidenced by higher supplier performance and on-time, in-full metrics. By integrating analytics, optimization, and governance in a single, explainable framework, SPOM equips procurement leaders to negotiate from insight, institutionalize best-value decisions, and safeguard patient supply while achieving durable cost efficiency. The model offers a replicable approach for diverse therapeutic areas and geographies and provides a platform for continuous improvement as regulations, technologies, and market conditions evolve. Future work will benchmark SPOM against alternative heuristics across sterile injectables and biologics categories and markets.
Keywords
Strategic Procurement; Pharmaceutical Manufacturing; Cost Efficiency; Total Cost of Ownership; Supplier Risk; Mixed-Integer Programming; Monte Carlo Simulation; Dual Sourcing; Vendor-Managed Inventory; Should-Cost Modeling; cGMP; Inventory Optimization.
References
[1] Abass, O. S., Balogun, O., & Didi, P. U. (2019). A predictive analytics framework for optimizing preventive healthcare sales and engagement outcomes. IRE Journals, 2(11), 497–503.
[2] Abou-El-Enein, M., Römhild, A., Kaiser, D., Beier, C., Bauer, G., Volk, H. D., & Reinke, P. (2013). Good Manufacturing Practices (GMP) manufacturing of advanced therapy medicinal products: a novel tailored model for optimizing performance and estimating costs. Cytotherapy, 15(3), 362-383.
[3] AbuKhousa, E., Al-Jaroodi, J., Lazarova-Molnar, S., & Mohamed, N. (2014). Simulation and modeling efforts to support decision making in healthcare supply chain management. The Scientific World Journal, 2014(1), 354246.
[4] AdeniyiAjonbadi, H., AboabaMojeed-Sanni, B., & Otokiti, B. O. (2015). Sustaining competitive advantage in medium-sized enterprises (MEs) through employee social interaction and helping behaviours. Journal of Small Business and Entrepreneurship, 3(2), 1-16.
[5] Aduwo, M. O., & Nwachukwu, P. S. (2019). Dynamic Capital Structure Optimization in Volatile Markets: A Simulation-Based Approach to Balancing Debt and Equity Under Uncertainty. IRE Journals, 3(2), 783–792.
[6] Aduwo, M. O., Akonobi, A. B., & Okpokwu, C. O. (2019). A Predictive HR Analytics Model Integrating Computing and Data Science to Optimize Workforce Productivity Globally. IRE Journals, 3(2), 798–807.
[7] Aduwo, M. O., Akonobi, A. B., & Okpokwu, C. O. (2019). Strategic Human Resource Leadership Model for Driving Growth, Transformation, and Innovation in Emerging Market Economies. IRE Journals, 2(10), 476–485.
[8] Ajayi, J. O., Bukhari, T. T., Oladimeji, O., & Etim, E. D. (2019). Toward zero-trust networking: A holistic paradigm shift for enterprise security in digital transformation landscapes. IRE Journals, 3(2), 2456–8880.
[9] Ajayi, J. O., Bukhari, T. T., Oladimeji, O., & Etim, E. D. (2019). A predictive HR analytics model integrating computing and data science to optimize workforce productivity globally. IRE Journals, 3(4), 2456–8880.
[10] Ajonbadi, H. A., & Mojeed-Sanni, B. A & Otokiti, BO (2015). ‘Sustaining Competitive Advantage in Medium-sized Enterprises (MEs) through Employee Social Interaction and Helping Behaviours.’. Journal of Small Business and Entrepreneurship Development, 3(2), 89-112.
[11] Ajonbadi, H. A., Lawal, A. A., Badmus, D. A., & Otokiti, B. O. (2014). Financial control and organisational performance of the Nigerian small and medium enterprises (SMEs): A catalyst for economic growth. American Journal of Business, Economics and Management, 2(2), 135-143.
[12] Ajonbadi, H. A., Otokiti, B. O., & Adebayo, P. (2016). The efficacy of planning on organisational performance in the Nigeria SMEs. European Journal of Business and Management, 24(3), 25-47.
[13] Akinbola, O. A., & Otokiti, B. O. (2012). Effects of lease options as a source of finance on profitability performance of small and medium enterprises (SMEs) in Lagos State, Nigeria. International Journal of Economic Development Research and Investment, 3(3), 70-76.
[14] Akinrinoye, O. V., Umoren, O., Didi, P. U., Balogun, O., & Abass, O. S. (2015, September). Predictive and segmentation-based marketing analytics framework for optimizing customer acquisition, engagement, and retention strategies. Engineering and Technology Journal, 10(9), 6758–6776.
[15] Akinrinoye, O. V., Umoren, O., Didi, P. U., Balogun, O., & Abass, O. S. (2019). Evaluating the strategic role of economic research in supporting financial policy decisions and market performance metrics. IRE Journals, 3(3), 248–258.
[16] Akomea-Agyin, K., & Asante, M. (2019). Analysis of security vulnerabilities in wired equivalent privacy (WEP). International Research Journal of Engineering and Technology, 6(1), 529-536.
[17] Akonobi, A. B., & Okpokwu, C. O. (2019). Designing a Customer-Centric Performance Model for Digital Lending Systems in Emerging Markets. IRE Journals, 3(4), 395–402. ISSN: 2456-8880
[18] Akpan, U. U., Adekoya, K. O., Awe, E. T., Garba, N., Oguncoker, G. D., & Ojo, S. G. (2017). Mini-STRs screening of 12 relatives of Hausa origin in northern Nigeria. Nigerian Journal of Basic and Applied Sciences, 25(1), 48-57.
[19] Akpan, U. U., Awe, T. E., & Idowu, D. (2019). Types and frequency of fingerprint minutiae in individuals of Igbo and Yoruba ethnic groups of Nigeria. Ruhuna Journal of Science, 10(1).
[20] Anthony, P., Adeleke, A. S., Gbaraba, S. V., Gado, P., & Ezeh, F. E. (2019). Community-based strategies for reducing drug misuse: Evidence from pharmacist-led interventions. Iconic Research and Engineering Journals, 2(8), 284–310. ISSN: 2456-8880
[21] Asante, M., & Akomea-Agyin, K. (2019). Analysis of security vulnerabilities in wifi-protected access pre-shared key.
[22] Atobatele, O. K., Ajayi, O. O., Hungbo, A. Q., & Adeyemi, C. (2019). Leveraging public health informatics to strengthen monitoring and evaluation of global health intervention. IRE Journals, 2(7), 174-193
[23] Atobatele, O. K., Hungbo A. Q., & Adeyemi, C. (2019). Evaluating strategic role of economic research in supporting financial policy decisions and market performance metrics. IRE Journals, 2(10), 442 – 452
[24] Atobatele, O. K., Hungbo, A. Q., & Adeyemi, C. (2019). Digital health technologies and real-time surveillance systems: Transforming public health emergency preparedness through data-driven decision making. IRE Journals, 3(9), 417–421. https://irejournals.com (ISSN: 2456-8880)
[25] Atobatele, O. K., Hungbo, A. Q., & Adeyemi, C. (2019). Leveraging big data analytics for population health management: A comparative analysis of predictive modeling approaches in chronic disease prevention and healthcare resource optimization. IRE Journals, 3(4), 370–375. https://irejournals.com (ISSN: 2456-8880)
[26] Awe, E. T. (2017). Hybridization of snout mouth deformed and normal mouth African catfish Clarias gariepinus. Animal Research International, 14(3), 2804-2808.
[27] Awe, E. T., & Akpan, U. U. (2017). Cytological study of Allium cepa and Allium sativum.
[28] Awe, E. T., Akpan, U. U., & Adekoya, K. O. (2017). Evaluation of two MiniSTR loci mutation events in five Father-Mother-Child trios of Yoruba origin. Nigerian Journal of Biotechnology, 33, 120-124.
[29] Ayanbode, N., Cadet, E., Etim, E. D., Essien, I. A., & Ajayi, J. O. (2019). Deep learning approaches for malware detection in large-scale networks. IRE Journals, 3(1), 483–502. ISSN: 2456-8880
[30] Balogun, O., Abass, O. S., & Didi, P. U. (2019). A multi-stage brand repositioning framework for regulated FMCG markets in Sub-Saharan Africa. IRE Journals, 2(8), 236–242.
[31] Bayeroju, O. F., Sanusi, A. N., Queen, Z., & Nwokediegwu, S. (2019). Bio-Based Materials for Construction: A Global Review of Sustainable Infrastructure Practices.
[32] Bukhari, T. T., Oladimeji, O., Etim, E. D., & Ajayi, J. O. (2018). A Conceptual Framework for Designing Resilient Multi-Cloud Networks Ensuring Security, Scalability, and Reliability Across Infrastructures. IRE Journals, 1(8), 164-173.
[33] Bukhari, T. T., Oladimeji, O., Etim, E. D., & Ajayi, J. O. (2019). Toward Zero-Trust Networking: A Holistic Paradigm Shift for Enterprise Security in Digital Transformation Landscapes. IRE Journals, 3(2), 822-831.
[34] Bukhari, T. T., Oladimeji, O., Etim, E. D., & Ajayi, J. O. (2019). A Predictive HR Analytics Model Integrating Computing and Data Science to Optimize Workforce Productivity Globally. IRE Journals, 3(4), 444-453.
[35] Cantrell, L., & Smith, L. B. (2013). Open questions and a proposal: A critical review of the evidence on infant numerical abilities. Cognition, 128(3), 331-352.
[36] Claassen, G. D. H. (2014). Optimization-based decision support systems for planning problems in processing industries. Wageningen University and Research.
[37] Cuppett, M. S. (2016). DevOps, DBAs, and DBaaS. DevOps, DBAs, and DBaaS, 73-85.
[38] Dako, O. F., Okafor, C. M., Farounbi, B. O., & Onyelucheya, O. P. (2019). Detecting financial statement irregularities: Hybrid Benford–outlier–process-mining anomaly detection architecture. IRE Journals, 3(5), 312–327.
[39] Didi, P. U., Abass, O. S., & Balogun, O. (2019). A multi-tier marketing framework for renewable infrastructure adoption in emerging economies. RE Journals, 3(4), 337–345.
[40] Didi, P. U., Abass, O. S., & Balogun, O. (2019). A predictive analytics framework for optimizing preventive healthcare sales and engagement outcomes. IRE Journals, 2(11), 497–503.
[41] Didi, P. U., Balogun, O., & Abass, O. S. (2019). A multi-stage brand repositioning framework for regulated FMCG markets in Sub-Saharan Africa. IRE Journals, 2(8), 236–242.
[42] Doherty, P. (2014). AIICS Publications: All Publications.
[43] Douglas, R. G., & Samant, V. B. (2017). The vaccine industry. Plotkin's Vaccines, 41.
[44] El Ata, N. A., & Perks, M. J. (2016). Solving the Dynamic Complexity Dilemma. Springer-Verlag Berlin An.
[45] Elasrag, H. (2018). Halal industry: Key challenges and opportunities.
[46] Erigha, E. D., Obuse, E., Ayanbode, N., Cadet, E., & Etim, E. D. (2019). Machine learning-driven user behavior analytics for insider threat detection. IRE Journals, 2(11), 535–544. (ISSN: 2456-8880)
[47] Essien, I. A., Cadet, E., Ajayi, J. O., Erigha, E. D., & Obuse, E. (2019). Cloud security baseline development using OWASP, CIS benchmarks, and ISO 27001 for regulatory compliance. IRE Journals, 2(8), 250–256. https://irejournals.com/formatedpaper/1710217.pdf
[48] Essien, I. A., Cadet, E., Ajayi, J. O., Erigha, E. D., & Obuse, E. (2019). Integrated governance, risk, and compliance framework for multi-cloud security and global regulatory alignment. IRE Journals, 3(3), 215–221. https://irejournals.com/formatedpaper/1710218.pdf
[49] Etim, E. D., Essien, I. A., Ajayi, J. O., Erigha, E. D., & Obuse, E. (2019). AI-augmented intrusion detection: Advancements in real-time cyber threat recognition. IRE Journals, 3(3), 225–231. https://irejournals.com/formatedpaper/1710369.pdf
[50] Evans-Uzosike, I. O., & Okatta, C. G. (2019). Strategic human resource management: trends, theories, and practical implications. Iconic Research and Engineering Journals, 3(4), 264-270.
[51] Farounbi, B. O., Akinola, A. S., Adesanya, O. S., & Okafor, C. M. (2018). Automated payroll compliance assurance: Linking withholding algorithms to financial statement reliability. IRE Journals, 1(7), 341–357.
[52] Festel, G., De Nardo, M., & Simmen, T. (2014). Outsourcing of pharmaceutical Manufacturing–a strategic partner selection process. Journal of Business Chemistry, 11(3), 117-132.
[53] Filani, O. M., Nwokocha, G. C., & Babatunde, O. (2019). Framework for Ethical Sourcing and Compliance Enforcement Across Global Vendor Networks in Manufacturing and Retail Sectors.
[54] Filani, O. M., Nwokocha, G. C., & Babatunde, O. (2019). Lean Inventory Management Integrated with Vendor Coordination to Reduce Costs and Improve Manufacturing Supply Chain Efficiency. continuity, 18, 19.
[55] Guttieres, D. G. (2018). Closing gaps in global access to biologic medicines: building tools to evaluate innovations in biomanufacturing (Doctoral dissertation, Massachusetts Institute of Technology).
[56] Haase, M., & Zimmermann, H. (2013). Scarcity, risk premiums, and the pricing of commodity futures: the case of crude oil contracts. The Journal of Alternative Investments, 16(1), 43.
[57] Hungbo, A. Q., & Adeyemi, C. (2019). Community-based training model for practical nurses in maternal and child health clinics. IRE Journals, 2(8), 217-235
[58] Hungbo, A. Q., & Adeyemi, C. (2019). Laboratory safety and diagnostic reliability framework for resource-constrained blood bank operations. IRE Journals, 3(4), 295-318. https://irejournals.com
[59] Khanna, I. (2012). Drug discovery in pharmaceutical industry: productivity challenges and trends. Drug discovery today, 17(19-20), 1088-1102.
[60] Kuglin, F. A. (2015). Pharmaceutical supply chain: Drug quality and security act. CRC Press.
[61] Laínez, J. M., Schaefer, E., & Reklaitis, G. V. (2012). Challenges and opportunities in enterprise-wide optimization in the pharmaceutical industry. Computers & chemical engineering, 47, 19-28.
[62] Lawal, A. A., Ajonbadi, H. A., & Otokiti, B. O. (2014). Leadership and organisational performance in the Nigeria small and medium enterprises (SMEs). American Journal of Business, Economics and Management, 2(5), 121.
[63] Lawal, A. A., Ajonbadi, H. A., & Otokiti, B. O. (2014). Strategic importance of the Nigerian small and medium enterprises (SMES): Myth or reality. American Journal of Business, Economics and Management, 2(4), 94-104.
[64] Lücker, F., & Seifert, R. W. (2017). Building up resilience in a pharmaceutical supply chain through inventory, dual sourcing and agility capacity. Omega, 73, 114-124.
[65] Luvai, H. (2018). Containing Risk when Maximizing Supply-Chain Performance. University of Missouri-Saint Louis.
[66] McLure, M. D. (2019). Toward Automated Sketching Collaborators: An Analogical Route (Doctoral dissertation, Northwestern University).
[67] Mehralian, G., Zarenezhad, F., & Rajabzadeh Ghatari, A. (2015). Developing a model for an agile supply chain in pharmaceutical industry. International Journal of Pharmaceutical and Healthcare Marketing, 9(1), 74-91.
[68] Menson, W. N. A., Olawepo, J. O., Bruno, T., Gbadamosi, S. O., Nalda, N. F., Anyebe, V., ... & Ezeanolue, E. E. (2018). Reliability of self-reported Mobile phone ownership in rural north-Central Nigeria: cross-sectional study. JMIR mHealth and uHealth, 6(3), e8760.
[69] Nsa, B., Anyebe, V., Dimkpa, C., Aboki, D., Egbule, D., Useni, S., & Eneogu, R. (2018, November). Impact of active case finding of tuberculosis among prisoners using the WOW truck in North Central Nigeria. The International Journal of Tuberculosis and Lung Disease, 22(11), S444. The International Union Against Tuberculosis and Lung Disease.
[70] Nsa, B., Anyebe, V., Dimkpa, C., Aboki, D., Egbule, D., Useni, S., & Eneogu, R. (2018). Impact of active case finding of tuberculosis among prisoners using the WOW truck in North Central Nigeria. The International Journal of Tuberculosis and Lung Disease, 22(11), S444.
[71] Nwokedi, C. N., Okoji, A. O., Saga, I., Oparah, S., & Ajayi, O. O. (2019). Children's rights in medical decision-making: Legal analysis of consent and capacity in pediatric care. IRE Journals, 2(11), 462–479.
[72] Nwokediegwu, Z. S., Bankole, A. O., & Okiye, S. E. (2019). Advancing interior and exterior construction design through large-scale 3D printing: A comprehensive review. IRE Journals, 3(1), 422-449. ISSN: 2456-8880
[73] Ogundipe, F., Sampson, E., Bakare, O. I., Oketola, O., & Folorunso, A. (2019). Digital Transformation and its Role in Advancing the Sustainable Development Goals (SDGs). transformation, 19, 48.
[74] Ogunsola, O. E. (2019). Climate diplomacy and its impact on cross-border renewable energy transitions. IRE Journals, 3(3), 296–302. https://irejournals.com/paper-details/1710672
[75] Ogunsola, O. E. (2019). Digital skills for economic empowerment: Closing the youth employment gap. IRE Journals, 2(7), 214–219. https://irejournals.com/paper-details/1710669
[76] Oguntegbe, E. E., Farounbi, B. O., & Okafor, C. M. (2019). Conceptual model for innovative debt structuring to enhance mid-market corporate growth stability. IRE Journals, 2(12), 451–463.
[77] Oguntegbe, E. E., Farounbi, B. O., & Okafor, C. M. (2019). Empirical review of risk-adjusted return metrics in private credit investment portfolios. IRE Journals, 3(4), 494–505.
[78] Oguntegbe, E. E., Farounbi, B. O., & Okafor, C. M. (2019). Framework for leveraging private debt financing to accelerate SME development and expansion. IRE Journals, 2(10), 540–554.
[79] Okoji, A. O., Sagay, I., Oparah, S., Ajayi, O. O., & Nwokedi, C. N. (2019). Rights in medical decision-making: Legal analysis of consent and capacity in pediatric care. IRE Journals, 2(11), 2456–8880.
[80] Okoji, A. O., Sagay, I., Oparah, S., Ajayi, O. O., & Nwokedi, C. N. (2019). Mental health law reform and patient autonomy: A legal review of involuntary treatment status. 216, 2(8).
[81] Okoji, A. O., Sagay, I., Oparah, S., Ajayi, O. O., & Nwokedi, C. N. (2019). Digital health records and informed consent: Legal challenges in the adoption of electronic medical systems. IRE Journals, 3(4), 1–17.
[82] Oni, O., Adeshina, Y. T., Iloeje, K. F., & Olatunji, O. O. (2018). Artificial Intelligence Model Fairness Auditor For Loan Systems. Journal ID, 8993, 1162.
[83] Orlandi, N. (2014). The innocent eye: Why vision is not a cognitive process. Oxford University Press.
[84] Osabuohien, F. O. (2017). Review of the environmental impact of polymer degradation. Communication in Physical Sciences, 2(1).
[85] Osabuohien, F. O. (2019). Green Analytical Methods for Monitoring APIs and Metabolites in Nigerian Wastewater: A Pilot Environmental Risk Study. Communication In Physical Sciences, 4(2), 174-186.
[86] Otokiti, B. O. (2018). Business regulation and control in Nigeria. Book of readings in honour of Professor SO Otokiti, 1(2), 201-215.
[87] Otokiti, B. O., & Akorede, A. F. (2018). Advancing sustainability through change and innovation: A co-evolutionary perspective. Innovation: Taking creativity to the market. Book of Readings in Honour of Professor SO Otokiti, 1(1), 161-167.
[88] Ouma, A. M. (2018). Influence of value disciplines strategy on the management of efficiency levels in the pharmaceutical industry in Kenya (Doctoral dissertation, JKUAT).
[89] Oziri, S. T., Seyi-Lande, O. B., & Arowogbadamu, A. A.-G. (2019). Dynamic tariff modeling as a predictive tool for enhancing telecom network utilization and customer experience. Iconic Research and Engineering Journals, 2(12), 436–450.
[90] Poliquin, R. (2012). The breathless zoo: Taxidermy and the cultures of longing. Penn State Press.
[91] Rafati, L., & Poels, G. (2015, February). Towards model-based strategic sourcing. In Global Sourcing Workshop 2015 (pp. 29-51). Cham: Springer International Publishing.
[92] Sanusi, A. N., Bayeroju, O. F., Queen, Z., & Nwokediegwu, S. (2019). Circular Economy Integration in Construction: Conceptual Framework for Modular Housing Adoption.
[93] Scholten, J., Eneogu, R., Ogbudebe, C., Nsa, B., Anozie, I., Anyebe, V., Lawanson, A., & Mitchell, E. (2018, November). Ending the TB epidemic: Role of active TB case finding using mobile units for early diagnosis of tuberculosis in Nigeria. The International Journal of Tuberculosis and Lung Disease, 22(11), S392. The International Union Against Tuberculosis and Lung Disease.
[94] Scholten, J., Eneogu, R., Ogbudebe, C., Nsa, B., Anozie, I., Anyebe, V., ... & Mitchell, E. (2018). Ending the TB epidemic: role of active TB case finding using mobile units for early diagnosis of tuberculosis in Nigeria. The international Union Against Tuberculosis and Lung Disease, 11, 22.
[95] Seidman, G., & Atun, R. (2017). Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries. BMJ global health, 2(2).
[96] Seiter, A. (2010). A practical approach to pharmaceutical policy. World Bank Publications.
[97] Seyi-Lande, O. B., Arowogbadamu, A. A.-G., & Oziri, S. T. (2018). A comprehensive framework for high-value analytical integration to optimize network resource allocation and strategic growth. Iconic Research and Engineering Journals, 1(11), 76–91.
[98] Seyi-Lande, O. B., Oziri, S. T., & Arowogbadamu, A. A.-G. (2018). Leveraging business intelligence as a catalyst for strategic decision-making in emerging telecommunications markets. Iconic Research and Engineering Journals, 2(3), 92–105.
[99] Seyi-Lande, O. B., Oziri, S. T., & Arowogbadamu, A. A.-G. (2019). Pricing strategy and consumer behavior interactions: Analytical insights from emerging economy telecommunications sectors. Iconic Research and Engineering Journals, 2(9), 326–340.
[100] Shah, S., & Hasan, S. (2016). Procurement practices in project based manufacturing environments. In MATEC Web of Conferences (Vol. 76, p. 02007). EDP Sciences.
[101] Sharma, A., Adekunle, B. I., Ogeawuchi, J. C., Abayomi, A. A., & Onifade, O. (2019). IoT-enabled Predictive Maintenance for Mechanical Systems: Innovations in Real-time Monitoring and Operational Excellence.
[102] Singh, R. K., Kumar, R., & Kumar, P. (2016). Strategic issues in pharmaceutical supply chains: a review. International Journal of Pharmaceutical and Healthcare Marketing, 10(3), 234-257.
[103] Sinha, A. (2016). Globalizing India: How global rules and markets are shaping India's rise to power. Cambridge University Press.
[104] Susarla, N., & Karimi, I. A. (2012). Integrated supply chain planning for multinational pharmaceutical enterprises. Computers & Chemical Engineering, 42, 168-177.
[105] Thomas, R. J., Hourd, P. C., & Ratcliffe, E. (2012). Precision manufacturing for clinical-quality regenerative medicines.
[106] Umoren, O., Didi, P. U., Balogun, O., Abass, O. S., & Akinrinoye, O. V. (2019). Linking macroeconomic analysis to consumer behavior modeling for strategic business planning in evolving market environments. IRE Journals, 3(3), 203-213.
[107] Vaittinen, S. (2016). Supply Chain Management in a Highly Regulated Environment–a Case Study of Supplier GMP-Compliance Management in the Pharmaceutical Industry.
[108] Vishwakarma, V., Prakash, C., & Barua, M. K. (2016). A fuzzy-based multi criteria decision making approach for supply chain risk assessment in Indian pharmaceutical industry. International Journal of Logistics Systems and Management, 25(2), 245-265.
[109] Williams, D. J., Thomas, R. J., Hourd, P. C., Chandra, A., Ratcliffe, E., Liu, Y., ... & Archer, J. R. (2012). Precision manufacturing for clinical-quality regenerative medicines. Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences, 370(1973), 3924-3949.
How to cite this paper
@article{1711923,
author = {Oluwafunmilayo Kehinde Akinleye},
title = {Developing a Strategic Procurement Optimization Model for Cost Efficiency in Pharmaceutical Manufacturing},
journal = {Iconic Research And Engineering Journals},
year = {2019},
volume = {2},
number = {12},
pages = {563-586},
issn = {2456-8880},
url = {https://www.irejournals.com/formatedpaper/1711923.pdf},
abstract = {Pharmaceutical manufacturers face converging pressures from price controls, raw-material volatility, supply disruptions, and strict regulatory oversight, making procurement a decisive lever for durable cost efficiency. This paper proposes a Strategic Procurement Optimization Model (SPOM) tailored to pharmaceutical manufacturing that unifies demand forecasting, multi-criteria supplier evaluation, risk-adjusted total cost of ownership, and scenario-driven inventory policies. The model couples probabilistic demand signals with mixed-integer programming to allocate volumes across qualified suppliers while honoring current Good Manufacturing Practice (cGMP), audit status, and validated change-control requirements. It explicitly prices risk via Monte Carlo stress tests on lead times, yields, and currency exposures, producing service-level-constrained decisions that minimize expected landed cost. The SPOM architecture consists of three layers. The data and analytics layer consolidates internal consumption histories, quality deviations, supplier scorecards, and external market indices to build transparent should-cost models for active pharmaceutical ingredients, excipients, and packaging. The optimization layer encodes constraints for batch sizes, shelf-life, cold-chain requirements, audit status, and dual-sourcing rules; it evaluates price-volume breakpoints, near-shoring options, consignment or vendor-managed inventory, and capacity reservations. The governance layer embeds cross-functional tollgates and key risk indicators, aligning sourcing decisions with Quality, Regulatory Affairs, Supply Chain, and Finance. Implementation is staged: taxonomy harmonization; digital RFx with structured technical and quality questionnaires; baseline risk and cost diagnostics; optimization runs with what-if scenarios (supplier outage, lead-time shocks, currency swings, expedited freight caps); and execution through category roadmaps with measurable targets. A pilot design for a solid-dose portfolio indicates potential outcomes: 6?12% reduction in addressable spend via mix and price leverage; 15?25% decrease in working capital through right-sized safety stocks; and improved resilience evidenced by higher supplier performance and on-time, in-full metrics. By integrating analytics, optimization, and governance in a single, explainable framework, SPOM equips procurement leaders to negotiate from insight, institutionalize best-value decisions, and safeguard patient supply while achieving durable cost efficiency. The model offers a replicable approach for diverse therapeutic areas and geographies and provides a platform for continuous improvement as regulations, technologies, and market conditions evolve. Future work will benchmark SPOM against alternative heuristics across sterile injectables and biologics categories and markets.},
keywords = {Strategic Procurement; Pharmaceutical Manufacturing; Cost Efficiency; Total Cost of Ownership; Supplier Risk; Mixed-Integer Programming; Monte Carlo Simulation; Dual Sourcing; Vendor-Managed Inventory; Should-Cost Modeling; cGMP; Inventory Optimization.},
month = {June},
}